Sign Up to like & get
recommendations!
0
Published in 2017 at "Therapeutic Drug Monitoring"
DOI: 10.1097/ftd.0000000000000407
Abstract: Background: Anti-T lymphocyte globulin (ATLG) modulates the alloreactivity of T lymphocytes, reducing the risk of immunological posttransplant complications, in particular rejection and graft-versus-host disease, after allogeneic hematopoietic stem cell transplantation (HSCT). We developed and validated…
read more here.
Keywords:
anti lymphocyte;
new enzyme;
linked immunosorbent;
lymphocyte globulin ... See more keywords